Screening and Diagnosis of Prostate Cancer
Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.
EP: 1.Incidence and Risk Factors of Prostate Cancer
EP: 2.Presentation and Diagnosis of Prostate Cancer
EP: 3.Screening and Diagnosis of Prostate Cancer
EP: 4.Prostate Cancer Prognosis and Risk Stratification
EP: 5.Differences in the Treatment of Patients with Prostate Cancer
EP: 6.Prostate Cancer: Treatment Decision-Making and the Role of Guidelines
EP: 7.Informing Prostate Cancer Treatment Decisions with Clinical Trials and Real-World Evidence
EP: 8.Systemic Therapy for Prostate Cancer
EP: 9.Androgen Deprivation Therapy for Prostate Cancer
EP: 10.Metastatic Hormone-Sensitive Prostate Cancer Treatment Options
EP: 11.Overview of Castrate-Resistant Prostate Cancer (CRPC)
EP: 12.Treatment Options for Nonmetastatic CRPC
EP: 13.Treatment Approach for Patients With Metastatic CRPC
EP: 14.The Role of Combination Therapy in mCRPC
EP: 15.Improving Clinical Trials in Prostate Cancer
EP: 16.Educating Patients and Caregivers About Prostate Cancer
EP: 17.Advice for Patients With Prostate Cancer
This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of Dana-Farber Cancer Institute; Rashid K. Sayyid, MD, MSc, of the University of Toronto; and Reginald Tucker-Seeley, MA, ScM, ScD, of ZERO Prostate Cancer.
Dr Reginald Tucker-Seeley, MA, ScM, ScD, Vice President of Health Equity at ZERO Prostate Cancer, addresses prostate cancer screening guidelines that can be confusing across age groups. While screening starts at age 50, he notes men at high risk, including African Americans or those with family history, should talk to their primary care physician about screening in their 40s, per ZERO recommendations.
In terms of screening methods, Dr Tucker-Seeley outlines 3 tools endorsed by clinical guidelines – the prostate-specific antigen (PSA) blood test, digital rectal exam, and magnetic resonance imaging (MRI). He acknowledges men may be uncomfortable with the brief digital rectal exam but believes it’s worth enduring to save lives.
In summary, Dr Reginald Tucker-Seeley offers clarification on prostate cancer screening, recommending high-risk men to start discussions in their 40s given family history or genetic risk. He outlines the screening modalities per guidelines – PSA, digital rectal exam, and MRI – arguing the brief discomfort of the exam is justified to enable early detection and save lives.
*Video synopsis is AI-generated and reviewed by CURE editorial staff.
Dickey Betts Died, ‘Shopaholic’ Author Announces Cancer Diagnosis and More
April 19th 2024From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.
Read More
